MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

08 Nov 2023 Evaluate
A decrease of about -43.95% in the sales to Rs. 597.20 millions was observed for the quarter ended September 2023. The sales stood at Rs. 1065.40 millions during the similar quarter previous year.The Net Loss for the quarter ended September 2023 is Rs. -57.80 millions as compared to Net Loss of Rs. -172.80 millions of corresponding quarter ended September 2022Operating Profit saw a handsome growth to 357.90 millions from 220.30 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 597.20 1065.40 -43.95 1292.70 2110.20 -38.74 4025.50 3066.10 31.29
Other Income 387.10 208.80 85.39 531.50 250.10 112.51 521.60 603.90 -13.63
PBIDT 357.90 220.30 62.46 452.10 295.90 52.79 599.20 999.00 -40.02
Interest 174.20 136.20 27.90 351.80 262.20 34.17 579.20 372.30 55.57
PBDT 153.20 84.10 82.16 69.80 33.70 107.12 0.00 567.60 -100.00
Depreciation 245.80 352.00 -30.17 492.70 698.50 -29.46 962.00 1400.70 -31.32
PBT -92.60 -267.90 -65.43 -422.90 -664.80 -36.39 -962.00 -833.10 15.47
TAX -34.80 -95.10 -63.41 -151.80 -243.70 -37.71 -373.30 -528.40 -29.35
Deferred Tax -34.80 -95.10 -63.41 -151.80 -243.70 -37.71 -373.30 -221.60 68.46
PAT -57.80 -172.80 -66.55 -271.10 -421.10 -35.62 -588.70 -304.70 93.21
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 59.93 20.68 189.83 34.97 14.02 149.41 14.89 32.58 -54.32
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..